Scholars Central

Research articlePublished 31 Mar 2017

Midazolam vs. Meperidine plus Bupivacaine as spinal anaesthesia in woman undergoing caesarean surgery: clinical trial study

Authors: Habib Zakeri, Mona Rajabi, Mehrdad Badpa, Mahshid Abdollahi, Samira Salehi, Ali Hosseinipour

Biomedical Research

Volume 28 · Issue 6 · Pages 2768–2772

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: The rate of caesarean section has risen from less than 7% in 1970s to more than 25% in 2003. Objective: Due to the side effects of caesarean operation as well as the vital cares needed in this procedure, the raise in the ratio has expressed the technique as a matter of global concern. Methods: A total of 93 patients’ undergone caesarean sections under spinal anaesthesia with American Society of Anaesthesiologists Class 1 and 2 were included in the study. The patients were randomly divided into three groups of 31 persons. All 3 groups received 10 mg of 0.5% bupivacaine then 25 mg of meperidine was added for the second group and 2 mg of midazolam was used for the third group while the first group received placebo in addition to bupivacaine. RM-ANOVA, chi square, and ANOVA using Bonferroni correction method we used to compare the data. All analysis was done using SPSS 20. Pvalue less than 0.05 considered as the significant level. Results: For 10 (23.3%) subjects in the Midazolam group, 19 (61.3%) subjects in the meperidine group and 24 (77.4%) subjects in the placebo group were used anti-nausea medication. It indicates that the Midazolam group, used anti-nausea medication less than other groups (P=0.001). Immediately after spinal anaesthesia, the rate of pain was lower in the meperidine group (mean of pain score: 0.19) and it started later than other groups until 2 hours after anaesthesia. The frequency of pain was low until 3 hours after anaesthesia. Conclusion: This investigation demonstrates that meperidine for its longer duration of analgesia is better than midazolam while with regard to having fewer side effects, the reverse is preferable. So, injecting sufficient dosage of midazolam along with bupivacaine could be a good choice for additive drug.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Biomedical Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBiomedical Research
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Habib Zakeri”
  • BylineArticles whose byline prints “Mona Rajabi”
  • BylineArticles whose byline prints “Mehrdad Badpa”
  • BylineArticles whose byline prints “Mahshid Abdollahi”
  • BylineArticles whose byline prints “Samira Salehi”
  • BylineArticles whose byline prints “Ali Hosseinipour”